These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients]. Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103 [No Abstract] [Full Text] [Related]
8. Vaccinations against Pseudomonas aeruginosa: active and passive alternatives. Bellanti JA; Zeligs BJ; Kulczycki LL Pediatr Pulmonol Suppl; 1997; 16():269-70. PubMed ID: 9443307 [No Abstract] [Full Text] [Related]
9. The epidemiology of Pseudomonas aeruginosa and the development of a polyvalent vaccine. Pranter W; Staerk J; Zellner R; Zwisler O Prog Immunobiol Stand; 1971; 5():414-8. PubMed ID: 4633968 [No Abstract] [Full Text] [Related]
10. Development of immunotherapy for infections due to Pseudomonas aeruginosa. Fisher MW J Infect Dis; 1974 Nov; 130 Suppl(0):S149-51. PubMed ID: 4138585 [No Abstract] [Full Text] [Related]
11. Pseudomonas vaccination and immunotherapy: an overview. Holder IA J Burn Care Rehabil; 2001; 22(5):311-20. PubMed ID: 11570530 [No Abstract] [Full Text] [Related]
12. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns]. Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W Pol Tyg Lek; 1981 Aug; 36(32):1207-11. PubMed ID: 6798556 [No Abstract] [Full Text] [Related]
13. The efficiency of specific immunization with corpuscular vaccines in the treatment and prophylaxis of Pseudomonas aeruginosa infections of the bones. Denischi A; Meitert E; Cursaru A; Purghel E; Stăngulescu D; Sima F; Savulian C; Chersulick E; Petrescu AM; Costin M Arch Roum Pathol Exp Microbiol; 1987; 46(2):111-27. PubMed ID: 3138966 [No Abstract] [Full Text] [Related]
14. Pseudomonas aeruginosa: prevention better than cure? Mellor JA; Miler JJ Dev Biol Stand; 1979; 43():53-9. PubMed ID: 118071 [TBL] [Abstract][Full Text] [Related]
15. [Chemical components of pathogens and the mechanism of their virulence: Pseudomonas aeruginosa vaccine]. Homma Y; Tanimoto H Nihon Rinsho; 1986 Sep; 44(9):2016-21. PubMed ID: 3099035 [No Abstract] [Full Text] [Related]
16. A polyvalent Pseudomonas vaccine. Sato H; Diena BB Rev Can Biol; 1974 Jun; 33(2):93-7. PubMed ID: 4211759 [No Abstract] [Full Text] [Related]
17. Effect of carbenicillin, gentamicin and vaccines on rats experimentally burned and infected with Pseudomonas aeruginosa. Toama MA; Hamed IM; Ashour SM Pharmazie; 1980; 35(4):228-30. PubMed ID: 6773076 [TBL] [Abstract][Full Text] [Related]
18. [Infections in minks caused by Pseudomonas aeruginosa. Infection and vaccination trials]. Karlsson KA; Kull KE; Svanholm R Nord Vet Med; 1971; 23(7):345-51. PubMed ID: 5004400 [No Abstract] [Full Text] [Related]
19. Active immunization of burned patients with a new multivalent Staphylococcus-Pseudomonas vaccine. Sachs A Prog Immunobiol Stand; 1971; 5():428-32. PubMed ID: 4633971 [No Abstract] [Full Text] [Related]
20. Assessment of the effectiveness of antipseudomonas biological management in the control of infection in burn patients. Gonzáles Ayala SE; Daroda M; Villa J; Cecchini E; Vich J Panminerva Med; 1983; 25(3):203-8. PubMed ID: 6422426 [No Abstract] [Full Text] [Related] [Next] [New Search]